InsiderTrades

Form 4 for BMY Bristol Myers Squibb

Accepted 2023-06-06 00:00:00 ET · period of report 2023-06-03 · accession 0000014272-23-000119 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-06-06 2023-06-03 BMY Lenkowsky Adam EVP, Chief Commercial Off F - Tax $65.66 -551 526 -51% -$36.2K
D 2023-06-06 2023-06-03 BMY Lenkowsky Adam EVP, Chief Commercial Off M - OptEx $0.00 +1,077 1,077 New $0
D 2023-06-06 2023-06-03 BMY Lenkowsky Adam EVP, Chief Commercial Off M - OptEx $0.00 -1,077 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock, $0.10 par value 2023-06-03 F D 551 $65.66 526 D — — (F2) Shares withheld for payment of taxes upon vesting of award.
2 Common Common Stock, $0.10 par value 2023-06-03 M A 1,077 $0.00 1,077 D — — (F1) The restricted stock units vest in four equal installments beginning on June 3, 2020.
3 Derivative Restricted Stock Units 2023-06-03 M D 1,077 $0.00 0 D — · — to 2023-06-03 1,077 Common Stock, $0.10 par value (F4) Each restricted stock unit converts into one share of common stock upon vesting. (F1) The restricted stock units vest in four equal installments beginning on June 3, 2020.